跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
COPHADYL-E COUGH LINCTUS - HSA Drug Approval Details
Approvals
/
HSA
/
COPHADYL-E COUGH LINCTUS
Approved
THERAPEUTIC
COPHADYL-E COUGH LINCTUS
ICM PHARMA PTE. LTD. (SINGAPORE)
🇸🇬 Health Sciences Authority
Approval Date
Dec 28, 1996
Approval ID
76a0207f9033acfd
Company
ICM PHARMA PTE. LTD. (SINGAPORE)
Type
Therapeutic
Approval Details
Approval Id
76a0207f9033acfd
Drug Name
COPHADYL-E COUGH LINCTUS
Product Name
COPHADYL-E COUGH LINCTUS
Approval Number
SIN09104P
Approval Date
1996-12-28
Registrant
ICM PHARMA PTE. LTD.
Licence Holder
ICM PHARMA PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PHARMACY ONLY MEDICINES
Dosage Form
ELIXIR
Route Of Administration
ORAL
Atc Code
R05DA20
Atc Item Name
combinations
Pharma Manufacturer Name
ICM PHARMA PTE. LTD.
Active Ingredients
PROMETHAZINE HCl
3.6 mg/5 ml
EPHEDRINE HCl
6 mg/5 ml
CODEINE PHOSPHATE
9 mg/5 ml
CODEINE PHOSPHATE
9 MG/5 ML
EPHEDRINE HCL
6 MG/5 ML
PROMETHAZINE HCL
3.6 MG/5 ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Dec 28, 1996
Approval ID
76a0207f9033acfd
Type
Therapeutic
Back to HSA Approvals